US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 6.300
  • +0.140+2.27%
Close Dec 13 16:00 ET
  • 6.300
  • 0.0000.00%
Post 18:42 ET
929.75MMarket Cap-4.70P/E (TTM)

About Adaptive Biotechnologies Company

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Company Profile

SymbolADPT
Company NameAdaptive Biotechnologies
Listing DateJun 27, 2019
Issue Price20.00
Founded2009
CEOMr. Chad M. Robins
MarketNASDAQ
Employees709
Fiscal Year Ends12-31
Address1165 Eastlake Avenue East
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-659-0067
Websitehttp://www.adaptivebiotech.com

Company Executives

  • Name
  • Position
  • Salary
  • Chad M. Robins
  • Chairman of the Board and Chief Executive Officer
  • 8.90M
  • Dr. Harlan Robins, PhD
  • Chief Scientific Officer
  • 8.61M
  • Francis Lo
  • Chief People Officer
  • --
  • Dr. Sharon Benzeno, PhD
  • Chief Commercial Officer, Immune Medicine
  • 2.88M
  • Julie Rubinstein
  • President and Chief Operating Officer
  • 2.97M
  • Kyle Piskel
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Susan Bobulsky
  • Chief Commercial Officer, Minimal Residual Disease
  • --
  • Stacy L. Taylor
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Dr. Robert M. Hershberg, M.D.,PhD
  • Independent Director
  • 325.00K
  • Katey Einterz Owen
  • Independent Director
  • 310.00K
  • Dr. Michael J. Pellini,M.D.
  • Independent Director
  • 310.00K
  • Michelle Griffin
  • Independent Director
  • 330.00K
  • Peter M. Neupert
  • Lead Independent Director
  • 355.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data